← All trials
NCT04824365
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 12, 2021
- Primary completion
- May 31, 2022
- Completion date
- Jun 30, 2022
- First posted
- Apr 1, 2021
- Last posted
- Apr 29, 2021
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cellular SciencesLead sponsor
- Dynamic DNA LabsCollaborator
- Family First Medical Research CenterCollaborator
- People's Liberation Army of ChinaCollaborator
- Trinity Health CareCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.